Product image of Glucosio B. Braun (Glucose Monohydrate) supplied by GNH India

Glucosio B. Braun

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glucosio B. Braun (Glucose Monohydrate)

Glucosio B. Braun is an injectable solution that contains glucose monohydrate as its sole active ingredient. It is supplied as a sterile aqueous solution for intravenous administration, typically used in parenteral nutrition and fluid therapy. The product conforms to European Union pharmaceutical standards and is classified as a carbohydrate solution (ATC code B05BB). Administration is performed by trained healthcare professionals in hospital or clinic settings.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucosio B. Braun is indicated for several clinical situations where rapid provision of glucose and fluid volume is required.

  • Treatment of hypoglycemia when oral glucose is not feasible.
  • Component of parenteral nutrition regimens to supply carbohydrate calories.
  • Fluid and electrolyte replacement in patients unable to tolerate oral intake.
  • Expansion of extracellular fluid volume during resuscitation or surgery.
  • Dilution of other intravenous medications as a compatible carrier.

Side Effects

Adverse reactions to Glucosio B. Braun are generally related to its osmotic and caloric properties.

Common

  • Transient hyperglycemia, especially in patients with impaired glucose tolerance.
  • Local irritation or pain at the infusion site.
  • Mild electrolyte shifts such as decreased serum potassium.
  • Nausea or vomiting if administered rapidly.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Fluid overload with pulmonary edema in susceptible individuals.
  • Allergic reactions ranging from urticaria to anaphylaxis.
  • Hyperosmolar hyperglycemic state in diabetic patients.

Precautions & Warnings

Safe use of Glucosio B. Braun requires assessment of patient condition and monitoring during therapy.

  • Verify blood glucose levels before and during infusion to avoid hyperglycemia.
  • Assess fluid status; avoid in patients with congestive heart failure or renal impairment.
  • Use caution in neonates and pediatric patients due to limited metabolic capacity.
  • Monitor electrolytes, particularly potassium and sodium, during prolonged administration.
  • Do not exceed recommended infusion rates to prevent osmotic complications.
  • Store the solution according to manufacturer instructions and discard if visual inspection reveals particulates.

Avoid Interactions

Glucosio B. Braun may interact with other intravenous agents, influencing glucose balance or fluid status.

Avoid

  • Concurrent high‑dose insulin infusions without appropriate glucose monitoring.
  • Co‑administration with other hypertonic solutions that could exacerbate fluid overload.

Use with caution

  • Diuretics, which may alter electrolyte balance during glucose infusion.
  • Beta‑blockers, which can mask signs of hypoglycemia.
  • Corticosteroids, which increase glucose production and may raise serum glucose levels.

Frequently Asked Questions

The product contains glucose monohydrate as its sole active ingredient.

It is used for treating hypoglycemia, as part of parenteral nutrition, for fluid and electrolyte replacement, and to expand extracellular fluid volume during surgery or resuscitation.

Glucosio B. Braun is supplied as a sterile solution for intravenous injection and should be administered by qualified healthcare professionals.

Use in neonates and children should be approached with caution because of their limited ability to metabolize large glucose loads.

Blood glucose, fluid status, and electrolytes (especially potassium and sodium) should be regularly monitored throughout the infusion.

Common adverse effects include transient hyperglycemia, local infusion site irritation, mild electrolyte shifts, and nausea or vomiting if given rapidly.

Severe hyperglycemia, fluid overload with pulmonary edema, allergic reactions such as anaphylaxis, and hyperosmolar hyperglycemic state are considered serious and need prompt evaluation.

Concurrent high‑dose insulin infusions should be avoided unless glucose levels are closely monitored and adjusted.

Patients with congestive heart failure or significant fluid retention should be assessed carefully, as the solution can contribute to fluid overload.

The solution should be stored according to the manufacturer’s instructions, typically in a controlled temperature environment, and discarded if visual inspection shows particulates or discoloration.

It is classified under ATC code B05BB, which denotes carbohydrate solutions used for parenteral nutrition and fluid therapy.

Yes, it can serve as a compatible carrier for diluting certain intravenous medications, provided compatibility is confirmed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT